Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2023 of 6351
-
Inhaled drug aims to save transplanted lungs from silent threat
Disease control Stopped earlyThe objective of the trial is to assess the long-term safety and efficacy of L-CsA plus Standard of Care (SoC) in the treatment of BOS in single (SLT) and double lung transplant (DLT) recipients.
Phase 3 • Sponsor: Zambon SpA • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Can a common steroid gel quiet oral lichen planus by altering MicroRNAs?
Disease control CompletedAccording to recent research, microRNAs (miRNAs) may function as early disease indicators and contribute to the severity of a number of precancerous and malignant oral disorders. The aim of the present study, through a double-blind randomized controlled trial design, is to analyz…
Sponsor: University of Catania • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a higher dose of ustekinumab rescue Crohn's patients who lost response?
Disease control CompletedThe aim of the study is to investigate the effect of re-induction with ustekinumab ≈6mg/kg IV followed by two different maintenance dosing regimens 90 mg subcutaneous every 8 weeks (Q8W) vs 90 mg subcutaneous every 4 weeks(Q4W) on clinical, biological and pharmacological outcomes…
Phase 3 • Sponsor: Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Can an antioxidant supplement calm sickle cell blood cells?
Disease control CompletedMitoQ is commercially available as a dietary supplement and it has been tested as a potential drug in other diseases, but it has never been tested in patients with sickle cell disease. The goal of this research is to study if MitoQ, a molecule that works as an antioxidant by rem…
Sponsor: University of Pittsburgh • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Exercise may turn back the clock for HIV veterans
Disease control CompletedMost Veterans living with HIV are 50 years of age or older and can expect to live more than 20 years longer with HIV medication. However, despite this success, Veterans living with HIV are more likely to have age-related diseases and loss of fitness and muscle that place them at …
Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Sound waves vs. bone pain: can ultrasound replace radiation?
Symptom relief OngoingThe FURTHER study aims to evaluate the effectiveness and cost-effectiveness of MR-HIFU (alone or in combination with EBRT) compared to EBRT alone, the standard-of-care, as a palliative treatment option to relieve CIBP. The FURTHER study consists of a multicenter, three-armed rand…
Sponsor: UMC Utrecht • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
A 20-Year-Old immune regulator faces its biggest test against cold sores
Disease control Recruiting nowHerpes simplex virus (HSV) infection is very common, as most people will experience herpetic infection during their lifetime. The most common manifestation of HSV infection is sores which may appear at any age. No specific antiviral therapy is available to totally cure herpetic …
Phase 4 • Sponsor: Labo'Life • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Can a tissue flap beat a drain tube for liver cyst surgery?
Disease control CompletedThis prospective comparative study evaluated two surgical techniques for residual cavity management following conservative surgery for complicated hepatic cystic echinococcosis. Patients undergoing surgery were managed with either omentoplasty or tube drainage. The study aimed to…
Sponsor: Ataturk University • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Which surgery best eases thumb arthritis pain? a Head-to-Head test
Disease control OngoingA randomized comparison between trapeziectomy and trapeziometacarpal limited excision for thumb base osteoarthritis in 90 patients.
Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Free genetic testing offered to 27,500 people to find hidden cancer risks
Knowledge-focused Recruiting nowThis trial examines approaches to identify and care for individuals with inherited cancer syndrome. The purpose of this study is to offer no cost genetic testing to the general public. Researchers hope to learn the value of providing broad, public-wide testing for high risk cance…
Sponsor: OHSU Knight Cancer Institute • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
A pocket coach for back pain: can an app boost exercise adherence?
Disease control CompletedThe main objective is to assess the impact of smartphone application on adherence to a physical exercise program in chronic low back pain patients. Adherence to a physical exercise program will be assessed at the start of the protocol, at three weeks and six months. A control g…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New study tests if a gentler therapy can match exposure therapy for PTSD
Symptom relief Recruiting nowThe purpose of this study is to compare two kinds of therapy for Posttraumatic Stress Disorder (PTSD): exposure therapy (ET) and Interpersonal Psychotherapy (IPT). The results of this study will allow us to see if IPT and ET are equally effective in treating PTSD due to Military …
Sponsor: Weill Medical College of Cornell University • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
New combo therapy aims to tame kidney disease
Disease control Recruiting nowThe primary objective of this study is to evaluate the effectiveness of belimumab and intravenous rituximab co-administration at inducing a complete or partial remission (CR or PR) compared to rituximab alone in participants with primary membranous nephropathy. Background: Prim…
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New antibody takes on Hard-to-Treat cancers
Disease control OngoingPart 1 will be a dose escalation study of IV ICT01 (a monoclonal antibody targeting BTN3A) as monotherapy in patients with advanced solid or hematologic tumors, followed by a cohort examining the combination of ICT01 plus pembrolizumab (Keytruda). Part 2 will be a cohort expansio…
Phase 1/2 • Sponsor: ImCheck Therapeutics, an Ipsen company • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Brain implant study aims to cut seizures in epilepsy patients
Disease control Stopped earlyThe purpose of this post-approval study is to further evaluate the long-term safety and effectiveness of Medtronic DBS therapy for epilepsy on seizure reduction in newly implanted participants through 3 years of follow-up.
Sponsor: MedtronicNeuro • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New study tests best statin dose for seniors to prevent heart attacks
Prevention Recruiting nowOne of the most effective drug in the primary prevention of cardiovascular disease is statins. The protective effects of statin on developement of cardiovascular disease has been demonstrated in elderly individuals. Since side effects of statin are more common in elderly individu…
Phase 4 • Sponsor: Yonsei University • Aim: Prevention
Last updated Jun 27, 2026 07:58 UTC
-
Sugar pill or savior? supplement may cut insulin use in pregnancy diabetes
Disease control OngoingGestational diabetes mellitus (GDM) is defined as hyperglycemia first-diagnosed during pregnancy. Glycemic control reduces GDM-related complications. With the new diagnostic criteria of GDM, up to 25% of pregnant women have GDM, whereas it was previously 6-10% in France. Therefor…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New hope: drug may shield brain from CAR T-Cell therapy side effects
Disease control Stopped earlyThis phase II trial studies how well anakinra works in preventing severe chimeric antigen receptor T-cell-related encephalopathy syndrome after chimeric antigen receptor T-cell therapy in patients with large B-cell lymphoma that has come back or has not responded to treatment. Im…
Phase 2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New combo injection shows promise for tough head and neck cancers
Disease control CompletedThe purpose of this study is to assess the efficacy and safety of intratumoral (IT) ulevostinag PLUS pembrolizumab (MK-3475) compared to pembrolizumab alone as a first line treatment of adults with metastatic or unresectable, recurrent head and neck squamous cell carcinoma (HNSCC…
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Ultra-High-Resolution MRI could sharpen spine surgery planning
Diagnosis Recruiting nowHigh-resolution MRI (7 Tesla) of the spine is capable to differentiate osseous spurs from discus-material and better depict the compressed nerve in the neuroforamen compared to 3T MRI. Provide the surgeon with a detailed high-resolution anatomical image before surgery and potent…
Sponsor: Reto Sutter, MD • Aim: Diagnosis
Last updated Jul 17, 2026 00:00 UTC